Brief: Nexgel New Strategic Partner, Sequence Lifescience, Leads Financing With $5.5 Million To Complete Acquisition Of Celularity Degenerative Disease Segment
21/04/2026 14:09
April 21 (Reuters) - Celularity Inc CELU.O: NEXGEL NEW STRATEGIC PARTNER, SEQUENCE LIFESCIENCE™, LEADS FINANCING WITH $5.5 MILLION TO COMPLETE ACQUISITION OF CELULARITY DEGENERATIVE DISEASE SEGMENT Source text: ID:nGNX36GYx9 Further company coverage: CELU.O ((Reuters.Briefs@thomsonreuters.com;))